207 related articles for article (PubMed ID: 36151352)
21. Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience.
Li X; Shi J; Ge M; Shao Y; Huang J; Huang Z; Zhang J; Nie N; Zheng Y
PLoS One; 2013; 8(3):e56648. PubMed ID: 23554855
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
Scheinberg P; Wu CO; Nunez O; Young NS
J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.
Marsh JC; Bacigalupo A; Schrezenmeier H; Tichelli A; Risitano AM; Passweg JR; Killick SB; Warren AJ; Foukaneli T; Aljurf M; Al-Zahrani HA; Höchsmann B; Schafhausen P; Roth A; Franzke A; Brummendorf TH; Dufour C; Oneto R; Sedgwick P; Barrois A; Kordasti S; Elebute MO; Mufti GJ; Socie G;
Blood; 2012 Jun; 119(23):5391-6. PubMed ID: 22544699
[TBL] [Abstract][Full Text] [Related]
26. Outcome of children with severe acquired aplastic anemia treated with rabbit antithymocyte globulin and cyclosporine A.
Garanito MP; Carneiro JD; Odone Filho V; Scheinberg P
J Pediatr (Rio J); 2014; 90(5):523-7. PubMed ID: 24878006
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A.
Goldenberg NA; Graham DK; Liang X; Hays T
Pediatr Blood Cancer; 2004 Dec; 43(7):718-22. PubMed ID: 15390303
[TBL] [Abstract][Full Text] [Related]
28. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
[TBL] [Abstract][Full Text] [Related]
29. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
30. Recent developments in drug therapy for aplastic anemia.
Willis L; Rexwinkle A; Bryan J; Kadia TM
Ann Pharmacother; 2014 Nov; 48(11):1469-78. PubMed ID: 25184310
[TBL] [Abstract][Full Text] [Related]
31. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
[TBL] [Abstract][Full Text] [Related]
32. [Predicting early response to immunosuppressive therapy in severe aplastic anemia by soluble transferrin receptor assay].
Yang WR; Xiong YY; Zhang L; Jing LP; Zhou K; Peng GX; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):709-13. PubMed ID: 23978026
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
[No Abstract] [Full Text] [Related]
34. Immunosuppressive therapy with rabbit antithymocyte globulin therapy for acquired aplastic anemia: a multi-institutional retrospective study in Japanese adult patients.
Sasaki N; Shimura K; Yoshida M; Uoshima N; Kiyota M; Hatsuse M; Uchiyama H; Chinen Y; Kobayashi T; Nakao M; Takahashi R; Nakano-Akamatsu S; Kaneko H; Kobayashi Y; Shimazaki C; Taniwaki M; Kuroda J;
Int J Hematol; 2019 Mar; 109(3):278-285. PubMed ID: 30627868
[TBL] [Abstract][Full Text] [Related]
35. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
[TBL] [Abstract][Full Text] [Related]
36. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
Peffault de Latour R; Kulasekararaj A; Iacobelli S; Terwel SR; Cook R; Griffin M; Halkes CJM; Recher C; Barraco F; Forcade E; Vallejo JC; Drexler B; Mear JB; Smith AE; Angelucci E; Raymakers RAP; de Groot MR; Daguindau E; Nur E; Barcellini W; Russell NH; Terriou L; Iori AP; La Rocca U; Sureda A; Sánchez-Ortega I; Xicoy B; Jarque I; Cavenagh J; Sicre de Fontbrune F; Marotta S; Munir T; Tjon JML; Tavitian S; Praire A; Clement L; Rabian F; Marano L; Hill A; Palmisani E; Muus P; Cacace F; Frieri C; van Lint MT; Passweg JR; Marsh JCW; Socié G; Mufti GJ; Dufour C; Risitano AM;
N Engl J Med; 2022 Jan; 386(1):11-23. PubMed ID: 34986284
[TBL] [Abstract][Full Text] [Related]
37. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
38. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Jalaeikhoo H; Khajeh-Mehrizi A
PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
[TBL] [Abstract][Full Text] [Related]
39. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
[TBL] [Abstract][Full Text] [Related]
40. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
